Highlights the substantial short-term risk of recurrent thromboembolic events in patients with active cancer who experience an acute ischemic stroke.
Patients with acute ischemic stroke in the setting of active cancer (especially adenocarcinoma) face a substantial short-term risk of recurrent ischemic stroke and other types of thromboembolism.
Navi et al. (Thu,) studied this question.